Chemotactic-like receptors and Aβ peptide induced responses in Alzheimer's disease

Neurobiology of Aging

Volumn 21, Issue 3, 2000, Pages 463-473

  Lorton, Dianne ^a   Schaller, Jill ^a   Lala, Amitabha ^b   De Nardin, Ernesto ^b  

^a SUN HEALTH RESEARCH INSTITUTE   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

amyloid peptide; Alzheimer's disease; Chemotactic receptors; IL 1

Indexed keywords

AMYLOID BETA PROTEIN; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CHEMOTACTIC PEPTIDE; GUANINE NUCLEOTIDE BINDING PROTEIN; INTERLEUKIN 1BETA; LACTATE DEHYDROGENASE; PEPTIDE; RECEPTOR; CHEMOKINE RECEPTOR; CHEMOTACTIC FACTOR; FORMYLMETHIONYLLEUCYLPHENYLALANINE; INTERLEUKIN 1;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; ARTICLE; CHEMOTAXIS; CYTOKINE RELEASE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; INFLAMMATION; MICROGLIA; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; METABOLISM; RAT;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; CHEMOTACTIC FACTORS; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-1; L-LACTATE DEHYDROGENASE; MICROGLIA; MONOCYTES; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; PEPTIDES; RATS; RECEPTORS, CHEMOKINE;

EID: 0034611814     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(00)00092-0     Document Type: Article

References (47)

1. Araujo D.M., Cotman C.W. β-Amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer's disease. Brain Research. 569:1992;141-145.
2. Becker E.L., Bleich H.E., Day A.R., Freer R.J., Glasel J.A., Visintainer J. Nuclear magnetic resonance conformational studies on the chemotactic tripeptide formyl-L-leucyl-L-phenylalanine. A small beta sheet. Biochemistry. 18:1979;4656-4668.
3. Behl C., Davis J.B., Lesley R., Schubert D. Hydrogen peroxide mediates amyloid β protein toxicity. Cell. 77:1994;817-827.
4. Bonora G.M., Toniolo C., Freer R.J., Becker E.L. Retro-all-D and retro isomers of a formyl peptide chemoattractant an insight into the mode of binding at the receptor on rabbit neutrophils . Biochim Biophys Acta. 884:1986;545-549.
5. Boulay F., Tardif M., Brouchon L., Vignais P. Synthesis and use of a novel N-formyl peptide derivative to isolate a human N-formyl peptide receptor cDNA. Biochem Biophys Res Commun. 168:1990;1103.
6. Chatterjee A., Parthasarathy R. Conformation and hydrogen bonding of N-formylmethionyl peptides. Parallel beta-sheet in the crystal structure of N-formyl-L-methionyl-L-valine. Int J Pept Protein Res. 24:1984;447-452.
7. Chin J., Kostura M.J. Dissociation of IL-1β synthesis and secretion in human blood monocytes stimulated with bacterial cell wall products. J Immunol. 151:1993;5574-5585.
8. Collins S.J. The HL-60 promyelocytic leukemia cell line proliferation, differentiation, and cellular oncogene expression . Blood. 70:1987;1233.
9. Davis J.B., McMurray G.F., Schubert D. The amyloid beta-protein or Alzheimer's disease is chemotactic for mononuclear phagocytes. Biochem Biophy Res Commun. 189:1992;1096-1100.
10. El Khoury J., Hickman S.E., Thomas C.A., Cao L., Silverstein S.C., Lolke J.D. Scavenger receptor-mediated adhesion of microglia to β-amyloid fibrils. Nature. 382:1996;716-719.
11. Gavuzo E., Mazza F., Pochetti G., Scatturin A. Crystal structure, conformation, and potential energy calculations of the chemotactic peptide N-formyl-L-Met-L-Leu-L-Phe-OMe. Int J Pept Protein Res. 34:1989;409-415.
12. 5a anaphylatoxin. Nature. 349:1991;614.
13. Gitter B.D., Cox L.M., Rydel R.E., May P.C. Amyloid β peptide potentiates cytokine secretion by interleukin-1β-activated human astrocytoma cells. Proc Natl Acad Sci USA. 92:1995;10738-10741.
14. Harris P., Ralph P. Human leukemic models of myelomonocytic development of the HL-60 and U937 cell lines. J Leukocyte Biol. 37:1985;407.
15. Hensley K., Carney J.M., Mattson M.P., et al. A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide relevance to Alzheimer's disease . Proc Natl Acad Sci USA. 91:1994;3270-3274.
16. Holmes W.E., Lee J., Kuang W.J., Rice G.C., Wood W.I. Structure and functional expression of a human interleukin-8 receptor. Science. 253:1991;1278.
17. Joshi S.N., Crutcher K.A. Rat microglia exhibit increased density on Alzheimer's plaques in vitro. Exp Neurol. 149:1998;42-50.
18. Kernen P., Wymann M.P., von Tscharner V., et al. Shape changes, exocytosis, and cytosolic free calcium changes in stimulated human eosinophils. J Clin Invest. 87:1991;2012.
19. Kita H., Ohnishi T., Okubo Y., Weiler D., Abrams J.S., Gleich G.J. Granulocyte/macrophage colony-stimulating factor and interleukin 3 release from human peripheral blood eosinophils and neutrophils. J Exp Med. 174:1991;745.
20. Kita H., Abu-Ghazaleh R.I., Gleich G.J., Abraham R.T. Role of pertussis toxin-sensitive G proteins in stimulus-dependent human eosinophil degranulation. J Immunol. 147:1991;3466.
21. Klegeris A., Walker D.G., McGeer P.L. Activation of macrophages by Alzheimer β amyloid peptide. Biochem Biophys Res Commun. 199:1994;984-991.
22. Klegeris A., Walker D.G., McGeer P.L. Interaction of Alzheimer β-amyloid peptide with the human monocyte cell line THP-1 results in a protein kinase C-dependent secretion of tumor necrosis factor-α Brain Research. 747:1997;114-121.
23. Kupper R.W., Dewald B., Jakobs K.H., Baggiolini M., Gierschik P. G-protein activation by IL-8 and related cytokines in human neutrophil plasma membranes. Biochem J. 28:1992;429-434.
24. Lala A, Sojar HT, De Nardin E. Expression and purifiaction of recombinant human N-formyl-L-leucyl-L-phenylalanine (FMLP) receptor: generation of polyclonal antibody against FMLP receptor. Biochem Pharmacol 54:381-90.
25. Levy R., Rotrosen D., Nagauker O., Leto T.L., Malech H.L. Induction of the respiratory burst in HL-60 cells correlation of function and protein expression . J Immunol. 145:1990;2595.
26. Lorton D., Kocsis J.M., King L., Madden K., Brunden K.R. β-Amyloid peptides induce elevated release of interleukin-1β from activated human monocyte. J Neuroimmunol. 67:1996;21-29.
27. Lorton D. β-Amyloid-induced IL-1β release from an activated human monocyte cell line is calcium- and G-protein-dependent. Mech Ageing and Dev. 94:1997;199-211.
28. Majde J. Commercially available serum-free medium appropriate for studies of macrophage functions in vitro. J Immunol Meth. 115:1988;89-93.
29. May P.C., Gitter B.D., Waters D.C., Simmons L.K., Becker G.W., Small J.S., Robinson P.M. β-Amyloid peptide in vitro toxicity lot-to-lot variability. Neurobiol Aging. 13:1992;605-607.
30. Meda L., Cassatella M.A., Szendral G.L., et al. Activation of microglial cells by β-amyloid protein and interferon-γ Nature. 374:1995;647-650.
31. Murphy P.M. The molecular biology of leukocyte chemoattractant receptors. Annu Rev Immunol. 12:1994;593-633.
32. Pagani Zecchini G., Paglialunga Paradisi M., Torrinin I., et al. Synthesis, conformation, and activity of HCO-Met-delta Z Leu-Phe-OMe, an active analogue of chemotactic N-formyltripeptides. Biopolymers. 33:1993;437-451.
33. Parthasarathy R., Fridey S.M., Srikrishnan T. Conformation and hydrogen bonding of N-formylmethionyl peptides. II. Crystal and molecular structure of N-formyl-L-methionyl-L-phenylalanine. Int J Pept Protein Res. 33:1989;308-312.
34. Pike C.J., Walencewicz A.J., Glabe C.G., Cotman C.W. Aggregation-related toxicity of synthetic β-amyloid protein in hippocampal cultures. Eur J Pharmacol. 207:1991;367-368.
35. Pike C.J., Burdick D., Walencewicz A.J. Neurodegeneration induced by beta-amyloid peptides in vitro the role of peptide assembly state . J Neurosci. 13:1993;1676-1687.
36. Rao D.M., Misukonis M.A., Cohen H.J., Weinberg J.B. Cooperative effect of tumor necrosis factor and gamma-interferon on chemotactic peptide receptor expression and stimulus-induced actin polymerization in HL-60 cells. Blood. 71:1988;1062.
37. Schultz J., Schaller J., McKinley M., et al. Enhanced cytotoxicity of amyloid β-peptide by a complement dependent mechanism. Neurosci Lett. 175:1994;99-102.
38. Sedgewick J.G., Vrtis R.R., Goureley M.F., Busse W.W. Stimulus-dependent differences in superoxide anion generation by normal human eosinophils and neutrophils. J Allergy Clin Immunol. 81:1988;876.
39. Shaffer L.M., Dority M.D., Gupta-Bansal R., Frederickson R.C.A., Younkin S.G., Brunden K.R. Amyloid β protein removal by neuroglial cells in culture. Neurobiol Aging. 16:1995;737-745.
40. Snyderman R, Uhing RJ. Chemoattractant stimulus-response coupling. In: Gallin JI, Goldstein IM, Snyderman R, editors. Inflammation: basic principles and clinical correlates, 2nd edition. New York: Raven, 1992. p. 421-39.
41. Tamura N., Agrawal D.K., Townley R.G. Leukotriene C4 production from human eosinophils in vitro. Role of eosinophil chemotactic factors in eosinophil activation. J Immunol. 141:1988;4291.
42. Torrini I., Pagani Zecchini G., Paglialunga Paradisi M., Lucente G., Gavuzo E., Mazza R. Synthesis and properties of chemotactic peptide analogs. II. HCO-Met-Leu-Phe-OMe analogs containing cyclic appha, alpha-disubstituted amino acids as Met and Phe mimicking residues. Int J Pept Protein Res. 38:1991;495-504.
43. Vertuani G., Spisani S., Boggian M., Traniello S., Scatturin A. Conformational studies of synthetic tripeptide chemoattractants. Int J Pept Protein Res. 29:1987;525-532.
44. Walker D.G., Kim S.U., McGeer P.L. Complement and cytokine gene expression in cultured microglial derived from postmortem human brains. J Neurosci Res. 40:1995;478-493.
45. Yan S.D., Chen X., Fu J., et al. RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease. Nature. 382:1996;685-691.
46. Yankner B.A., Buffy L.K., Kirschner D.A. Neurotrophic and neurotoxic effects of amyloid β protein reversal by tachykinin neuropeptides . Science. 250:1990;279-282.
47. Ye R.D., Prossnitz E.R., Zou A.H., Cochrane C.G. Characterization of a human cDNA that encodes a functional receptor for platelet activating factor. Biochem Biophys Res Commun. 180:1991;105.